First Manhattan’s Chimerix, Inc. CMRX Stock Holding History

First Manhattan’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,000	Closed	-$2.12K	–	1378
2024 Q1	$2.12K	Buy	+2,000	New	+$2.08K	﹤0.01%	1274

Other funds holding CMRX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Manhattan's CMRX Position: Q2 2024 in Review

First Manhattan sold out of Chimerix, Inc. (CMRX) in Q2 2024, closing a stake of 2,000 shares — an estimated $2.12K sold.

First Manhattan first reported a position in CMRX in Q1 2024 and held it in 1 quarter. The position peaked at $2.12K in Q1 2024. 73 funds tracked by Wall St. Rank hold CMRX as of Q2 2024.

First Manhattan reported no remaining Chimerix, Inc. position as of Q2 2024 after selling out during the quarter.
First Manhattan sold 2,000 Chimerix, Inc. shares in Q2 2024, an estimated $2.12K.
First Manhattan first reported a position in Chimerix, Inc. in Q1 2024 and held it in 1 quarter.
First Manhattan's Chimerix, Inc. position peaked at $2.12K in Q1 2024.
73 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.